Site: |
Dana Farber Cancer Institute |
|||
Address: |
450 Brookline Ave |
|||
City: |
Boston |
|||
State: |
MA |
|||
Zip: |
02215-5450 |
|||
Country: |
USA |
1 |
Ongoing, but not recruiting |
Closed |
Sunitinib + Regorafenib |
NCT02164240 |
|
1 |
Ongoing, but not recruiting |
Closed |
Cobimetinib + MPDL3280A |
NCT01988896 |
|
1 |
Ongoing, but not recruiting |
Closed |
KTN0158 |
NCT02642016 |
|
2 |
Not yet recruiting |
Not yet activated |
Bezuclastinib plus Sunitinib |
NCT06208748 |
|
3 |
No longer avalable |
Closed |
Regorafenib (BAY 73-4506) |
NCT01646593 |
|
2 |
Does not allow GIST |
Closed |
R1507 |
NCT00642941 |
|
3 |
Completed |
Closed |
Nilotinib |
NCT00471328 |
|
3 |
Completed |
Closed |
Nilotinib |
NCT00488150 |
|
3 |
Completed |
Closed |
Sunitinib |
NCT00075218 |
|
3 |
Completed |
Closed |
Nilotinib or Imatinib |
NCT00785785 |
|
2 |
Completed |
Closed |
XL820 |
NCT00570635 |
|
2 |
Completed |
Closed |
Imatinib |
NCT00237185 |
|
2 |
Completed |
Closed |
SU5416 |
NCT00005862 |
|
2 |
Completed |
Closed |
Imatinib |
NCT00867113 |
|
2 |
Completed |
Closed |
STA-9090 |
NCT01039519 |
|
2 |
Completed |
Closed |
Imatinib + RAD001 |
NCT01275222 |
|
2 |
Completed |
Closed |
Imatinib + AT13387 |
NCT01294202 |
|
2 |
Completed |
Not yet activated |
Linsitinib (OSI-906) |
NCT01560260 |
|
2 |
Completed |
Closed |
Sunitinib |
NCT01396148 |
|
2 |
Completed |
Closed |
Ponatinib (Iclusig) |
NCT01874665 |